Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Intern & Resident, Internal Medicine, Beth Israel Deaconess Medical Center 2015 - 2018
  • M.D., University of Connecticut, School of Medicine 2015
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kelsey, M. D., & Newby, L. K. (2022). In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y. Ann Intern Med, 175(11), JC126. https://doi.org/10.7326/J22-0085
       Full Text  Link to Item
    • Rao, V. N., Mentz, R. J., Coniglio, A. C., Kelsey, M. D., Fudim, M., Fonarow, G. C., … Caughey, M. C. (2022). Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry. Circ Heart Fail, 15(11), e009353. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009353
       Full Text  Link to Item
    • Grant, J. K., Snow, S., Kelsey, M., Rymer, J., Schaffer, A. E., Patel, M. R., … Shah, N. P. (2022). Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach. Curr Cardiol Rep, 24(10), 1373–1385. https://doi.org/10.1007/s11886-022-01751-z
       Full Text  Link to Item
    • O’Toole, T., Kelsey, M. D., Shah, N. P., McGarrah, R. W., & Pagidipati, N. J. (2022). Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs. Curr Cardiol Rep, 24(10), 1397–1406. https://doi.org/10.1007/s11886-022-01760-y
       Full Text  Link to Item
    • Drescher, C. S., Kelsey, M. D., Yankey, G. S., Sun, A. Y., Wang, A., Sadeghpour, A., … Kelsey, A. M. (2022). Imaging Considerations and Clinical Implications of Mitral Annular Disjunction. Circ Cardiovasc Imaging, 15(9), e014243. https://doi.org/10.1161/CIRCIMAGING.122.014243
       Full Text  Link to Item
    • Kelsey, M. D., & Newby, L. K. (2022). Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C. Ann Intern Med, 175(8), JC86. https://doi.org/10.7326/J22-0060
       Full Text  Link to Item
    • Kelsey, M. D., Nelson, A. J., Green, J. B., Granger, C. B., Peterson, E. D., McGuire, D. K., & Pagidipati, N. J. (2022). Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. J Am Coll Cardiol, 79(18), 1849–1857. https://doi.org/10.1016/j.jacc.2022.02.046
       Full Text  Link to Item
    • Kelsey, M. D., Patrick-Lake, B., Abdulai, R., Broedl, U. C., Brown, A., Cohn, E., … Bloomfield, G. S. (2022). Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Contemp Clin Trials, 116, 106740. https://doi.org/10.1016/j.cct.2022.106740
       Full Text  Link to Item
    • Kelsey, M. D., & Newby, L. K. (2022). In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality. Ann Intern Med, 175(3), JC26. https://doi.org/10.7326/J22-0003
       Full Text  Link to Item
    • Nanna, M. G., Vemulapalli, S., Fordyce, C. B., Mark, D. B., Patel, M. R., Al-Khalidi, H. R., … Douglas, P. S. (2022). The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. Am Heart J, 245, 136–148. https://doi.org/10.1016/j.ahj.2021.12.004
       Full Text  Link to Item
    • Nelson, A. J., O’Brien, E. C., Kaltenbach, L. A., Green, J. B., Lopes, R. D., Morse, C. G., … Granger, C. B. (2022). Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. Jama Netw Open, 5(2), e2148030. https://doi.org/10.1001/jamanetworkopen.2021.48030
       Full Text  Link to Item
    • Rao, V. N., Kelsey, M. D., Blazing, M. A., Pagidipati, N. J., Fortin, T. A., & Fudim, M. (2022). Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make. Circ Heart Fail, 15(2), e008982. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008982
       Full Text  Link to Item
    • Kelsey, M., & Pagidipati, N. (2021). Towards a personalised approach for obesity treatment: one size does not fit all. Heart, 107(19), 1526–1527. https://doi.org/10.1136/heartjnl-2021-319726
       Full Text  Link to Item
    • Kelsey, M., Page, C., Alhanti, B., Rhodes, S. L., Kent, S. T., Peterson, E., & Pagidipati, N. (2021). Lipoprotein(a) Testing Patterns in a Large Health System. Am J Cardiol, 153, 43–50. https://doi.org/10.1016/j.amjcard.2021.05.018
       Full Text  Link to Item
    • Kelsey, M. D., & Granger, C. B. (2021). LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in Mexico. Ann Intern Med, 174(5), JC59. https://doi.org/10.7326/ACPJ202105180-059
       Full Text  Link to Item
    • Rao, V. N., Kelsey, M. D., Kelsey, A. M., Russell, S. D., Mentz, R. J., Patel, M. R., & Fudim, M. (2021). Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic. Clin Cardiol, 44(5), 656–664. https://doi.org/10.1002/clc.23590
       Full Text  Link to Item
    • Kelsey, M. D., & Newby, L. K. (2020). In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med, 173(12), JC71. https://doi.org/10.7326/ACPJ202012150-071
       Full Text  Link to Item
    • Kelsey, M. D., & Newby, L. K. (2020). In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year. Ann Intern Med, 173(6), JC28. https://doi.org/10.7326/ACPJ202009150-028
       Full Text  Link to Item
    • Kelsey, M. D. (2015). Aporia in Medicine. Conn Med, 79(6), 365–366.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.